Barclays lowered the firm’s price target on Visteon (VC) to $130 from $135 and keeps an Equal Weight rating on the shares. The company’s Q3 EBITDA was inline with estimates but its growth was disappointing, the analyst tells investors in a research note.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VC: